These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 28874235

  • 1. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
    Li HH, Reshef A, Baker JW, Harper JR, Relan A.
    Allergy Asthma Proc; 2017 Nov 05; 38(6):456-461. PubMed ID: 28874235
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
    Baker JW, Bernstein JA, Harper JR, Relan A, Riedl MA.
    Allergy Asthma Proc; 2018 Sep 28; 39(5):359-364. PubMed ID: 29954477
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
    Riedl MA, Li HH, Cicardi M, Harper JR, Relan A.
    Allergy Asthma Proc; 2017 Nov 13; 38(6):462-466. PubMed ID: 28903805
    [Abstract] [Full Text] [Related]

  • 4. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
    Baker JW, Reshef A, Moldovan D, Harper JR, Relan A, Riedl MA.
    J Allergy Clin Immunol Pract; 2017 Nov 13; 5(4):1091-1097. PubMed ID: 28202404
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, Triggiani M, Montinaro V, Cillari E, Realdi G, Cancian M, Visscher S, Zanichelli A, Relan A, Cicardi M.
    Clin Exp Allergy; 2012 Jun 13; 42(6):929-35. PubMed ID: 22909164
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
    Reshef A, Grivcheva-Panovska V, Kessel A, Kivity S, Klimaszewska-Rembiasz M, Moldovan D, Farkas H, Gutova V, Fritz S, Relan A, Giannetti B, Magerl M.
    Pediatr Allergy Immunol; 2019 Aug 13; 30(5):562-568. PubMed ID: 30993784
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
    Riedl M.
    Clin Drug Investig; 2015 Jul 13; 35(7):407-17. PubMed ID: 26091744
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A, Caccia S, Cicardi M.
    Expert Rev Clin Immunol; 2018 Sep 13; 14(9):707-718. PubMed ID: 30021471
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
    Andrási N, Veszeli N, Holdonner Á, Temesszentandrási G, Kőhalmi KV, Varga L, Farkas H.
    Int Immunopharmacol; 2020 Mar 13; 80():106216. PubMed ID: 31982824
    [Abstract] [Full Text] [Related]

  • 10. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
    Riedl MA, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I.
    Ann Allergy Asthma Immunol; 2012 Jan 13; 108(1):49-53. PubMed ID: 22192966
    [Abstract] [Full Text] [Related]

  • 11. Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.
    Farkas H, Csuka D, Veszeli N, Zotter Z, Szabó E, Varga L.
    Allergy Asthma Proc; 2014 Jan 13; 35(3):255-9. PubMed ID: 24801469
    [Abstract] [Full Text] [Related]

  • 12. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ, Bewtra AK, Hurewitz D, Levy R, Janss G, Jacobson KW, Packer F, Bernstein JA, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.
    Allergy Asthma Proc; 2012 Jan 13; 33(4):354-61. PubMed ID: 22856636
    [Abstract] [Full Text] [Related]

  • 13. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
    Riedl MA, Lumry WR, Li HH, Craig TJ, Fitts D, Kalfus I, Uknis ME.
    Am J Rhinol Allergy; 2013 Jan 13; 27(6):517-21. PubMed ID: 24274230
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.
    Valerieva A, Staevska MT, Grivcheva-Panovska V, Jesenak M, Kőhalmi KV, Hrubiskova K, Zanichelli A, Bellizzi L, Relan A, Hakl R, Farkas H.
    World Allergy Organ J; 2021 Apr 13; 14(4):100535. PubMed ID: 33995818
    [Abstract] [Full Text] [Related]

  • 15. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ, Bewtra AK, Bahna SL, Hurewitz D, Schneider LC, Levy RJ, Moy JN, Offenberger J, Jacobson KW, Yang WH, Eidelman F, Janss G, Packer FR, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.
    Allergy; 2011 Dec 13; 66(12):1604-11. PubMed ID: 21884533
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
    Bork K, Bernstein JA, Machnig T, Craig TJ.
    J Emerg Med; 2016 Apr 13; 50(4):567-80.e1. PubMed ID: 26826769
    [Abstract] [Full Text] [Related]

  • 17. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
    Craig TJ, Rojavin MA, Machnig T, Keinecke HO, Bernstein JA.
    Ann Allergy Asthma Immunol; 2013 Sep 13; 111(3):211-5. PubMed ID: 23987198
    [Abstract] [Full Text] [Related]

  • 18. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
    Bernstein JA, Tyson C, Relan A, Adams P, Magar R.
    J Manag Care Spec Pharm; 2020 Feb 13; 26(2):203-210. PubMed ID: 31841366
    [Abstract] [Full Text] [Related]

  • 19. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
    Lumry WR, Zuraw B, Cicardi M, Craig T, Anderson J, Banerji A, Bernstein JA, Caballero T, Farkas H, Gower RG, Keith PK, Levy DS, Li HH, Magerl M, Manning M, Riedl MA, Lawo JP, Prusty S, Machnig T, Longhurst H, on behalf of the COMPACT Investigators.
    Orphanet J Rare Dis; 2021 Feb 15; 16(1):86. PubMed ID: 33588897
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
    Riedl MA, Bernstein JA, Li H, Reshef A, Lumry W, Moldovan D, Farkas H, Levy R, Baker J, Hardiman Y, Totoritis MC, Relan A, Cicardi M, Study 1310 Investigators.
    Ann Allergy Asthma Immunol; 2014 Feb 15; 112(2):163-169.e1. PubMed ID: 24468257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.